Literature DB >> 11346458

Expression of gp34 (OX40 ligand) and OX40 on human T cell clones.

N Takasawa1, N Ishii, N Higashimura, K Murata, Y Tanaka, M Nakamura, T Sasaki, K Sugamura.   

Abstract

gp34, which we previously cloned, is a ligand of OX40 (CD134), a costimulatory molecule involved in T cell activation. To elucidate the role of human OX40 / OX40L interaction, we examined the expression of gp34 (OX40L) and OX40 in normal human hematopoietic cells by using flow cytometry. OX40 expression is observed on activated T cells, while OX40L is expressed in antigen-presenting cells. However, cytotoxic T lymphocyte (CTL) clones specific for Epstein-Barr virus (EBV)-transformed autologous lymphoblastic cell lines (LCLs) induced both OX40 and OX40L expression after antigen or T cell receptor (TCR) stimulation. This study suggests a possible function of OX40L / OX40, through T cell-T cell interaction, in the reactivation of memory T cells in an autocrine manner, with implications for the pathogenesis of viral infections and neoplasms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346458      PMCID: PMC5926725          DOI: 10.1111/j.1349-7006.2001.tb01105.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  31 in total

1.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection.

Authors:  M Kopf; C Ruedl; N Schmitz; A Gallimore; K Lefrang; B Ecabert; B Odermatt; M F Bachmann
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

3.  Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I.

Authors:  K Ohtani; A Tsujimoto; T Tsukahara; N Numata; S Miura; K Sugamura; M Nakamura
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

4.  Expression and function of OX40 ligand on human dendritic cells.

Authors:  Y Ohshima; Y Tanaka; H Tozawa; Y Takahashi; C Maliszewski; G Delespesse
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

5.  CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.

Authors:  H Akiba; H Oshima; K Takeda; M Atsuta; H Nakano; A Nakajima; C Nohara; H Yagita; K Okumura
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

6.  Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis.

Authors:  A D Weinberg; D N Bourdette; T J Sullivan; M Lemon; J J Wallin; R Maziarz; M Davey; F Palida; W Godfrey; E Engleman; R J Fulton; H Offner; A A Vandenbark
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

7.  The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen.

Authors:  U Latza; H Dürkop; S Schnittger; J Ringeling; F Eitelbach; M Hummel; C Fonatsch; H Stein
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

8.  Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells.

Authors:  E Stüber; M Neurath; D Calderhead; H P Fell; W Strober
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

9.  Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.

Authors:  P R Baum; R B Gayle; F Ramsdell; S Srinivasan; R A Sorensen; M L Watson; M F Seldin; E Baker; G R Sutherland; K N Clifford
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

10.  Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.

Authors:  L S Walker; A Gulbranson-Judge; S Flynn; T Brocker; C Raykundalia; M Goodall; R Förster; M Lipp; P Lane
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  14 in total

Review 1.  Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.

Authors:  Shahram Salek-Ardakani; Michael Croft
Journal:  J Interferon Cytokine Res       Date:  2010-04       Impact factor: 2.607

2.  Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.

Authors:  Itzhak Mendel; Ethan M Shevach
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 3.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 4.  Roles of OX40 in the pathogenesis and the control of diseases.

Authors:  Toshiyuki Hori
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

5.  Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.

Authors:  Peyman Rajabi; Mahsa Alaee; Kazem Mousavizadeh; Ali Samadikuchaksaraei
Journal:  Inflamm Res       Date:  2012-07-31       Impact factor: 4.575

6.  Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C.

Authors:  Dina Montufar-Solis; John R Klein
Journal:  Curr Immunol Rev       Date:  2005-01

Review 7.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

8.  Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

Authors:  Peter T Jindra; Susan E Conway; Stacy M Ricklefs; Stephen F Porcella; Sarah L Anzick; Mike Haagenson; Tao Wang; Stephen Spellman; Edgar Milford; Peter Kraft; David H McDermott; Reza Abdi
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-05       Impact factor: 5.742

9.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

10.  Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.

Authors:  Xingqiang Lai; Zhongpeng Yao; Fen Ning; Lei Zhang; Jiali Fang; Guanghui Li; Lu Xu; Yunyi Xiong; Luhao Liu; Rongxin Chen; Junjie Ma; Zheng Chen
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.